Short answer
Oncology Institute, Inc. (TOI) filed an 8-K current report with the SEC on May 22, 2026 reporting Item 1.05 (Material Cybersecurity Incidents), Item 7.01 (Regulation FD Disclosure). Follow-up disclosure under Item 1.05, indicating a previously reported cybersecurity incident.
- This filing includes Item 1.05, an item that often signal trouble.
Oncology Institute, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.05 · Material Cybersecurity Incidents
- Follow-up disclosure under Item 1.05, indicating a previously reported cybersecurity incident
- Limited excerpt provides no new details on scope, affected data, operational impact, or remediation
Item 7.01 · Regulation FD Disclosure
- Vendor cybersecurity incident involved unauthorized access to Company systems containing patient data
- Investigation remains ongoing, with potential legal, regulatory, reputational, remediation and patient-notification costs
- Operations, financial systems and quality of care not materially affected as of filing date
- Company plans credit monitoring and protection for impacted patients while reserving claims against third parties
- Vendor patient portal established for affected individuals and incident-related inquiries
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oncology Institute, Inc. 8-K filings
Get the next TOI 8-K as it lands
Follow TOI for push alerts, or ask the research agent what this filing means.